경제
중도 성향
India's pharma takes 'wait-and-watch' approach to tackle Trump's 200% tariff plan | What next?
Mint (India)
Donald Trump announced a plan to bring drug manufacturing back to the U.S., imposing zero tariffs on imported generics for two years, then increasing to 100% and 200%. ...
이 뉴스, 어떠셨어요?
탭 한 번으로 반응 · 로그인 불필요
관련 뉴스
26건 · 22개 매체진보 성향 19%중도 성향 38%보수 성향 43%
4개 매체8개 매체9개 매체
관련 뉴스 제보는 로그인 후 가능합니다.
'economy' 카테고리 뉴스
I upgraded to premium economy on a long flight I've taken over 40 times. Next time, I'm choosing it over business class.
Business Insider
Super Micro Computer stock surged after AI server margins doubled what it expected
Quartz
GE Vernova raised its 2026 revenue forecast after strong earnings beat expectations
Quartz
Mint의 다른 기사
India-US trade deal could be signed in 3-4 months: US official says, ‘Only one major step remaining’ | Read here
Mint (India)
Dubai's City Ambassador Programme offers rewards worth ₹79,000 for inviting friends, family
Mint (India)
Sonam Wangchuk claims Centre promised to consider Pradhan's resignation over NEET paper leak row
Mint (India)